Brown Advisory US Smaller Companies PLC (BASC.L)
GBp 1425.0
(0.89%)
GBp 1425.0
(0.89%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -713 Thousand | - | - | - | - | - |
| Net Income | 4.72 Million | 15.3 Million | -25.41 Million | 47.45 Million | -5.65 Million | 6.27 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 17 Thousand | - | - | - | - | - |
| Other non-cash items | -5.45 Million | -15.3 Million | 25.41 Million | -47.45 Million | 5.65 Million | -6.27 Million |
| Investing Cash Flow | -745 Thousand | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -42.12 Million | - | - | - | - | - |
| Sales/Maturities of investments | 41.38 Million | - | - | - | - | - |
| Other Investing Activities | -745 Thousand | - | - | - | - | - |
| Financing Cash Flow | -1.19 Million | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.19 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -12 Thousand | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 29 Thousand | - | - | - | - | - |
| Cash at beginning of period | 12.44 Million | - | - | - | - | - |
| Cash at end of period | 9.72 Million | - | - | - | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -65 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -2.72 Million | - | - | - | - | - |
| Free Cash Flow | -713 Thousand | - | - | - | - | - |
| Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 667.5 Thousand | 667.5 Thousand | 1.63 Million | 1.63 Million | 15.3 Million | 3.11 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -6000.00 | -6000.00 | - | - | - | - |
| Other non-cash items | -839.5 Thousand | -839.5 Thousand | -1.8 Million | -1.8 Million | -15.3 Million | -3.11 Million |
| Investing Cash Flow | -1.07 Million | -1.07 Million | 705 Thousand | 705 Thousand | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -18.97 Million | - | - | - |
| Sales/Maturities of investments | - | - | 20.38 Million | - | - | - |
| Other Investing Activities | -1.07 Million | -1.07 Million | 705 Thousand | 705 Thousand | - | - |
| Financing Cash Flow | -599.5 Thousand | -599.5 Thousand | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -599.5 Thousand | -599.5 Thousand | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -6000.00 | -6000.00 | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 12.44 Million | - | - | - |
| Cash at end of period | -1.82 Million | -1.82 Million | 13.37 Million | 466.5 Thousand | - | - |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 27.5 Thousand | 27.5 Thousand | -60 Thousand | -60 Thousand | - | - |
| Net cash flow / Change in cash | -1.82 Million | -1.82 Million | 933 Thousand | 466.5 Thousand | - | - |
| Free Cash Flow | -178 Thousand | -178 Thousand | -178.5 Thousand | -178.5 Thousand | - | - |
SAURASHCEM
301180
SRGXF
SEB
PPL-PA
JBCHEPHARM